Heather S Mitchell

Summary

Affiliation: Victorian Cervical Cytology Registry
Country: Australia

Publications

  1. ncbi request reprint Influences on the risk of recurrent high grade cervical abnormality
    H Mitchell
    Victorian Cervical Cytology Registry, Carlton, South Victoria, Australia
    Int J Gynecol Cancer 12:728-34. 2002
  2. ncbi request reprint Longitudinal analysis of histologic high-grade disease after negative cervical cytology according to endocervical status
    H S Mitchell
    Victorian Cervical Cytology Registry, Carlton South, Victoria, Australia
    Cancer 93:237-40. 2001
  3. ncbi request reprint Improvement in protection against adenocarcinoma of the cervix resulting from participation in cervical screening
    Heather Mitchell
    Victorian Cervical Cytology Registry, Melbourne, Victoria, Australia
    Cancer 99:336-41. 2003
  4. ncbi request reprint Outcome after a cytological prediction of glandular abnormality
    Heather S Mitchell
    Victorian Cervical Cytology Registry, 752 Swanston Street, Carlton, Victoria 3052, Australia
    Aust N Z J Obstet Gynaecol 44:436-40. 2004
  5. ncbi request reprint Cervical cytology screening history of women diagnosed with adenocarcinoma in situ of the cervix: a case-control study
    Heather Mitchell
    Victorian Cervical Cytology Registry, Macfarlane Burnet Institute for Medical Research and Public Health, and Victorian Cytology Service, Melbourne, Australia
    Acta Cytol 48:595-600. 2004
  6. ncbi request reprint Laboratory performance measures: evidence against low-risk women explaining low detection rates of high-grade abnormalities
    H S Mitchell
    Victorian Cervical Cytology Registry, Carlton South, Vic, Australia
    Cytopathology 16:77-81. 2005
  7. ncbi request reprint Outcome after a cervical cytology report of low-grade squamous abnormality in Australia
    Heather Mitchell
    Victorian Cervical Cytology Registry, Carlton South, Australia
    Cancer 105:185-93. 2005
  8. ncbi request reprint How much cervical cancer is being prevented?
    Heather S Mitchell
    Med J Aust 178:298. 2003
  9. ncbi request reprint Prevention of cervical cancer
    Annabelle Farnsworth
    Douglass Hanly Moir Pathology, 95 Epping Road, North Ryde, NSW 2113, Australia
    Med J Aust 178:653-4. 2003

Detail Information

Publications9

  1. ncbi request reprint Influences on the risk of recurrent high grade cervical abnormality
    H Mitchell
    Victorian Cervical Cytology Registry, Carlton, South Victoria, Australia
    Int J Gynecol Cancer 12:728-34. 2002
    ..We conclude the risk of recurrent high-grade epithelial abnormality is related to the age and degree of abnormality on the incident biopsy. Screening policies should acknowledge the risk does not diminish with time...
  2. ncbi request reprint Longitudinal analysis of histologic high-grade disease after negative cervical cytology according to endocervical status
    H S Mitchell
    Victorian Cervical Cytology Registry, Carlton South, Victoria, Australia
    Cancer 93:237-40. 2001
    ..There is concern that Papanicolaou (Pap) smears without an endocervical component may be associated with the incomplete detection of abnormalities...
  3. ncbi request reprint Improvement in protection against adenocarcinoma of the cervix resulting from participation in cervical screening
    Heather Mitchell
    Victorian Cervical Cytology Registry, Melbourne, Victoria, Australia
    Cancer 99:336-41. 2003
    ..The impact of improved endocervical sampling and better recognition of the cytologic precursors to adenocarcinoma during the 1990s in reducing the risk of adenocarcinoma is currently unknown...
  4. ncbi request reprint Outcome after a cytological prediction of glandular abnormality
    Heather S Mitchell
    Victorian Cervical Cytology Registry, 752 Swanston Street, Carlton, Victoria 3052, Australia
    Aust N Z J Obstet Gynaecol 44:436-40. 2004
    ..The availability of population-based Australian data on the outcome after a cytology prediction of glandular abnormality was considered relevant to revising the recommended investigations for women with these abnormalities...
  5. ncbi request reprint Cervical cytology screening history of women diagnosed with adenocarcinoma in situ of the cervix: a case-control study
    Heather Mitchell
    Victorian Cervical Cytology Registry, Macfarlane Burnet Institute for Medical Research and Public Health, and Victorian Cytology Service, Melbourne, Australia
    Acta Cytol 48:595-600. 2004
    ..To determine whether women diagnosed with adenocarcinoma in situ (AIS) of the cervix are as well screened as healthy control women...
  6. ncbi request reprint Laboratory performance measures: evidence against low-risk women explaining low detection rates of high-grade abnormalities
    H S Mitchell
    Victorian Cervical Cytology Registry, Carlton South, Vic, Australia
    Cytopathology 16:77-81. 2005
    ..This study was undertaken to explore the hypothesis that a low-risk group of women were screened by Victorian laboratories not meeting the recommended minimum standard for the detection of high-grade abnormalities...
  7. ncbi request reprint Outcome after a cervical cytology report of low-grade squamous abnormality in Australia
    Heather Mitchell
    Victorian Cervical Cytology Registry, Carlton South, Australia
    Cancer 105:185-93. 2005
    ..The current study was undertaken to assist with providing an evidence-based approach to the management of women with cervical cytology reports of low-grade squamous abnormality as used in the Australian organized screening program...
  8. ncbi request reprint How much cervical cancer is being prevented?
    Heather S Mitchell
    Med J Aust 178:298. 2003
  9. ncbi request reprint Prevention of cervical cancer
    Annabelle Farnsworth
    Douglass Hanly Moir Pathology, 95 Epping Road, North Ryde, NSW 2113, Australia
    Med J Aust 178:653-4. 2003
    ..For a sustainable program, cost-containment issues need to be considered; screening interval, management of screen-detected abnormalities, and new technologies are the critical drivers of cost...